Avoid prescribing hypnotics. Hypnotics licensed for short term use only - If needed, use for 1-3 days only. Do not supply on discharge from hospital.
On specialist advice only, some patients with long term psychiatric problems may require long term use.
Zopiclone |
Formulary
|
Tablets 3.75mg, 7.5mg
|
|
Daridorexant |
Formulary
|
Tablets 25mg, 50mg Treatment of long-term insomnia |
NICE TA922: Daridorexant for treating long-term insomnia |
|
Melatonin |
Formulary
|
Children with learning disabilities Children with ADHD Children and adolescents with Autism Spectrum Disorder (ASD) and / or Smith-Magenis syndrome Cerebral palsy Children with complex neurodevelopmental disorders that the specialist considers eligible
Initiation of melatonin must be by a specialist in the indication being prescribed for and have a clear plan for review. Prescribing and review of melatonin in children must follow the principles outlined in the Melatonin Pathway (Children) |
LSCMMG: Melatonin Pathway (Children) |
|
Melatonin |
Formulary
|
For the Treatment of Rapid Eye Movement (REM) Sleep Behaviour Disorder (RBD) in Parkinson’s Disease and Lewy Body Dementia Adults with learning disabilities Sleep disturbance in adults with ADHD Sleep disorders in the blind Adults with complex neurodevelopmental disorders that the specialist considers eligible
Initiation of melatonin must be by a specialist in the indication being prescribed for and have a clear plan for review. Prescribing and review of melatonin in adults must follow the principles outlined in the Melatonin Pathway (adults) **Under development**. Melatonin is suitable for prescribing for the treatment of REM RBD in PD and LBD when clonazepam is not considered to be appropriate. |
LSCMMG: Melatonin |
|
Melatonin |
Formulary
|
Primary insomnia in those over 55 Sleep problems in patients with dementia associated with Alzheimer’s Colonis liquid 1mg/ml and 3mg tablets for all indications, including insomnia and jet lag |
LSCMMG: Melatonin |
|
Zolpidem |
Formulary
|
Tablets 5mg, 10mg |
MHRA: Zolpidem: risk of drowsiness and reduced driving ability |
|